Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 29 symbols : Snynf save search
New England Journal of Medicine Publishes Positive Phase 3 Trial Results for REGEN-COV™ (casirivimab and imdevimab) to Treat COVID-19
Published: 2021-09-29 (Crawled : 21:00) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -0.02%
H: 0.2%
C: -0.31%
REGN | News | $906.84 0.74% 0.74% 340K
|
Health Technology
|
| O: 0.17%
H: 0.96%
C: -0.42%
covid positive results casirivimab phase 3 trial trial results
Breckenridge Announces Approval of its ANDA for Teriflunomide Tablets (generic for Aubagio®)
Published: 2021-09-29 (Crawled : 18:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.13%
H: 0.93%
C: -0.14%
approval
IDWeek Presentations Highlight Continued Response to COVID-19
Published: 2021-09-29 (Crawled : 18:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.13%
H: 0.93%
C: -0.14%
HGEN | $0.0361 -61.5% 120M
|
Health Technology
|
| O: 0.33%
H: 5.54%
C: -0.81%
covid presentation response covid-19
Expansion Therapeutics Widens Funding by $80 Million for RNA-Linked Research
Published: 2021-09-29 (Crawled : 17:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.13%
H: 0.93%
C: -0.14%
funding expansion research
Denali Therapeutics Announces Upcoming Presentations on EIF2B Activator DNL343 and RIPK1 Inhibitor SAR443820/DNL788 at the 2021 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) Meeting
Published: 2021-09-29 (Crawled : 13:15) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.13%
H: 0.93%
C: -0.14%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: 0.22%
H: 0.73%
C: -2.43%
presentation sclerosis
Janssen Showcases Recent Data in Relapsing Multiple Sclerosis at the 2021 European Committee for Treatment and Research in Multiple Sclerosis Congress
Published: 2021-09-29 (Crawled : 12:00) - prnewswire.com
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.12%
H: 1.02%
C: 0.63%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.13%
H: 0.93%
C: -0.14%
multiple sclerosis treatment europe sclerosis research
Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases
Published: 2021-09-29 (Crawled : 12:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.13%
H: 0.93%
C: -0.14%
disease neurodegenerative expansion
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.